Matrox highlights partnership results

TriMed Staff | | Health Imaging | Diagnostic Imaging
Matrox demonstrated the results of its various partnerships through an assortment of booths at the 33rd Annual AHRA show in San Antonio, Texas, this week. Following is a selection of products that the company showcased:
  • The low profile, single board PCI Express system, the AURORA VX Series which is able to power up to three displays.
  • The Matrox MED Series of display controller boards represents a top-to-bottom system that is capable of a scope of display configurations for landscape and portrait modes.
  • RAD AGP, PCI and PCIe display controller boards with dual output support for grayscale or color, analog or digital displays.
  • Matrox's TheatreVUE Series which is able to clone any portion of the primary display to an analog projector or large-screen display, suitable for theatre-style classrooms and operating room environments.
Matrox displayed products through a number of partner booths, including
Dynamic Imaging, EIZO, Emageon, Fujifilm Medical Systems, Intuitive Imaging Informatics, Radical Radiology, RamSoft, and Swissray International.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup